GLS and malignant colon neoplasm: The abnormal high expression of GLS is closely related to the cisplatin resistance phenotype of colon cancer cells, and inhibiting GLS1 can work in synergy with cisplatin to effectively induce the death of colon cancer cells, indicating that GLS may become a potential intervention target for improving the chemotherapy effect of colon cancer [31].